{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T04:03:20Z","timestamp":1780718600433,"version":"3.54.1"},"reference-count":9,"publisher":"International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IRDR"],"published-print":{"date-parts":[[2026,5,31]]},"DOI":"10.5582\/irdr.2025.01074","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T22:09:12Z","timestamp":1776895752000},"page":"173-182","source":"Crossref","is-referenced-by-count":0,"title":["Understanding the disease burden and unmet needs of patients with primary immunodeficiency in China: A quantitative study"],"prefix":"10.5582","volume":"15","author":[{"given":"Linguo","family":"Li","sequence":"first","affiliation":[{"name":"Chinese Organization for Rare Disorders, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinru","family":"Chen","sequence":"additional","affiliation":[{"name":"Chinese Organization for Rare Disorders, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zikai","family":"He","sequence":"additional","affiliation":[{"name":"Chinese Organization for Rare Disorders, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Li","sequence":"additional","affiliation":[{"name":"Chinese Organization for Rare Disorders, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rufang","family":"Huang","sequence":"additional","affiliation":[{"name":"Chinese Organization for Rare Disorders, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3542","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. McCusker C, Upton J, Warrington R. Primary immunodeficiency. Allergy Asthma Clin Immunol. 2018; 14:61.","DOI":"10.1186\/s13223-018-0290-5"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Shillitoe B, Bangs C, Guzman D, <i>et al<\/i>. The United Kingdom Primary Immune Deficiency (UKPID) registry 2012 to 2017. Clin Exp Immunol. 2018; 192:284-291.","DOI":"10.1111\/cei.13125"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Pasquali J, Korganow A. The French national registry of primary immunodeficiency diseases. Clin Immunol. 2010; 135:264-272.","DOI":"10.1016\/j.clim.2010.02.021"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Party ERW, Gathmann B, Binder N, Ehl S, Kindle G. The European internet-based patient and research database for primary immunodeficiencies: Update 2011. Clin Exp Immunol. 2011; 167:479-491.","DOI":"10.1111\/j.1365-2249.2011.04542.x"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Tangye SG, Al-Herz W, Bousfiha A, <i>et al<\/i>. Human inborn errors of Immunity: 2019 update on the classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol. 2020; 40:24-64.","DOI":"10.1007\/s10875-019-00737-x"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Xie S, Wu J, Xie F. Population norms for SF-6DV2 and EQ-5D-5L in China. Appl Health Econ Health Policy. 2022; 20:573-585.","DOI":"10.1007\/s40258-022-00715-2"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Shiroiwa T, Fukuda T. EQ-5D-Y population norms for Japanese children and adolescents. Pharmacoeconomics. 2021; 39:1299-1308.","DOI":"10.1007\/s40273-021-01063-0"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Luo N, Liu G, Li M, Guan H, Jin X, Rand-Hendriksen K. Estimating an EQ-5D-5L value set for China. Value Health. 2017; 20:662-669.","DOI":"10.1016\/j.jval.2016.11.016"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Zhou T, Guan H, Wang L, Zhang Y, Rui M, Ma A. Health-related quality of life in patients with different diseases measured with the EQ-5D-5L: A systematic review. Front Public Health. 2021; 9:675523.","DOI":"10.3389\/fpubh.2021.675523"}],"container-title":["Intractable &amp; Rare Diseases Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/irdr\/15\/2\/15_2025.01074\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T03:48:24Z","timestamp":1780717704000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/irdr\/15\/2\/15_2025.01074\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,31]]},"references-count":9,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.5582\/irdr.2025.01074","relation":{},"ISSN":["2186-361X","2186-3644"],"issn-type":[{"value":"2186-361X","type":"electronic"},{"value":"2186-3644","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,31]]},"article-number":"2025.01074"}}